Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
about
Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
@en
type
label
Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
@en
prefLabel
Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
@en
P4844
P6153
P1476
Phase II Trial of Fulvestrant ...... ed With an Aromatase Inhibitor
@en
P3098
NCT00423917
P580
2007-08-01T00:00:00Z
P582
2009-02-01T00:00:00Z